AVT NATURAL PRODUCTS
|
AVT NATURAL PRODUCTS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 4.26 | 3.17 | 3.50 | 5.08 | 4.78 |
| CEPS(Rs) | 5.00 | 4.08 | 4.41 | 5.96 | 5.73 |
| DPS(Rs) | 0.80 | 0.70 | 0.80 | 1.00 | 1.00 |
| Book NAV/Share(Rs) | 36.73 | 33.25 | 30.83 | 28.26 | 24.22 |
| Tax Rate(%) | 21.60 | 23.61 | 25.02 | 25.95 | 24.62 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.42 | 12.98 | 15.25 | 20.66 | 18.80 |
| EBIT Margin(%) | 12.75 | 12.89 | 14.99 | 18.77 | 18.06 |
| Pre Tax Margin(%) | 11.47 | 11.20 | 13.65 | 17.86 | 17.24 |
| PAT Margin (%) | 8.99 | 8.56 | 10.24 | 13.22 | 12.99 |
| Cash Profit Margin (%) | 10.57 | 11.02 | 12.90 | 15.51 | 15.55 |
| Performance Ratios | |||||
| ROA(%) | 8.15 | 7.17 | 9.52 | 15.95 | 16.66 |
| ROE(%) | 12.16 | 9.88 | 11.84 | 19.37 | 21.46 |
| ROCE(%) | 14.26 | 12.95 | 16.07 | 25.70 | 26.97 |
| Asset Turnover(x) | 0.91 | 0.84 | 0.93 | 1.21 | 1.28 |
| Sales/Fixed Asset(x) | 4.03 | 3.30 | 3.22 | 3.95 | 3.95 |
| Working Capital/Sales(x) | 1.51 | 1.30 | 1.31 | 1.61 | 1.90 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.25 | 0.30 | 0.31 | 0.25 | 0.25 |
| Receivable days | 100.44 | 86.26 | 81.12 | 69.69 | 66.58 |
| Inventory Days | 155.52 | 166.77 | 151.87 | 123.26 | 113.10 |
| Payable days | 125.52 | 116.45 | 71.69 | 47.71 | 49.73 |
| Valuation Parameters | |||||
| PER(x) | 12.64 | 17.05 | 23.96 | 15.57 | 27.29 |
| PCE(x) | 10.75 | 13.24 | 19.01 | 13.28 | 22.80 |
| Price/Book(x) | 1.46 | 1.62 | 2.72 | 2.80 | 5.39 |
| Yield(%) | 1.49 | 1.30 | 0.95 | 1.26 | 0.77 |
| EV/Net Sales(x) | 1.26 | 1.60 | 2.48 | 2.09 | 3.56 |
| EV/Core EBITDA(x) | 8.69 | 10.34 | 13.98 | 9.87 | 17.24 |
| EV/EBIT(x) | 9.77 | 12.31 | 16.47 | 11.07 | 19.69 |
| EV/CE(x) | 1.33 | 1.45 | 2.54 | 2.62 | 4.44 |
| M Cap / Sales | 1.15 | 1.47 | 2.47 | 2.07 | 3.55 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 27.62 | 8.04 | -11.15 | 4.07 | 15.31 |
| Core EBITDA Growth(%) | 19.39 | -5.90 | -25.44 | 6.62 | 45.02 |
| EBIT Growth(%) | 26.52 | -6.93 | -28.99 | 8.51 | 56.86 |
| PAT Growth(%) | 34.38 | -9.50 | -31.15 | 6.24 | 60.85 |
| EPS Growth(%) | 34.38 | -9.50 | -31.15 | 6.24 | 60.85 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.20 | 0.22 | 0.08 | 0.08 | 0.06 |
| Current Ratio(x) | 2.71 | 2.90 | 4.53 | 5.75 | 5.39 |
| Quick Ratio(x) | 1.56 | 1.62 | 2.57 | 2.98 | 2.66 |
| Interest Cover(x) | 9.96 | 7.65 | 11.21 | 20.52 | 21.93 |
| Total Debt/Mcap(x) | 0.14 | 0.13 | 0.03 | 0.03 | 0.01 |
Compare Financial Ratios of peers of AVT NATURAL PRODUCTS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AVT NATURAL PRODUCTS | ₹1,061.8 Cr | -0% | -1.7% | -7.4% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,151.1 Cr | -2.8% | -9.4% | -26.4% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,126.5 Cr | 0.1% | 5.6% | -3.7% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹892.0 Cr | -4.9% | -6.6% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹528.3 Cr | -0.9% | 0.4% | -3.9% | Stock Analytics | |
| NATH BIOGENES (INDIA) | ₹306.3 Cr | 4.3% | -1.3% | -16.5% | Stock Analytics | |
AVT NATURAL PRODUCTS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AVT NATURAL PRODUCTS | -0% |
-1.7% |
-7.4% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses
